Rubius Therapeutics Raises $100 Million in Crossover Financing Post author:Sam Post published:February 28, 2018 Post category:BioPharma Rubius Therapeutics has closed on an oversubscribed $100 million crossover financing. Source: BioSpace You Might Also Like Teva, Alder BioPharma Forge $200M Anti-CGRP-Based Therapy Pact January 7, 2018 Irvine Scientific Increases Production Capacity Of Dry Powder Media For Cell Culture September 25, 2017 FDA Head Postpones Layoff Notices of Thousands of Employees July 25, 2017
Irvine Scientific Increases Production Capacity Of Dry Powder Media For Cell Culture September 25, 2017
